- Q3'24 net sales of $462.3
million, net income of $32.3
million and earnings per diluted share of $1.81
- Q3'24 non-GAAP net income of $34.0
million and non-GAAP earnings per diluted share of
$1.89
- Delivered adjusted EBITDA and adjusted EBITDA margins of
$78.6 million and 17.0% respectively
in Q3'24
- Generated $141.5 million of
operating cash flow YTD; Net leverage ratio of 1.6x
CONSHOHOCKEN, Pa., Oct. 31,
2024 /PRNewswire/ -- Quaker Houghton ("the Company")
(NYSE: KWR), the global leader in industrial process fluids,
announced its third quarter 2024 results today.
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
($ in thousands,
except per share data)
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net sales
|
$
462,274
|
|
$
490,612
|
|
$ 1,395,600
|
|
$ 1,486,204
|
Net income attributable
to Quaker Chemical Corporation
|
32,346
|
|
33,670
|
|
102,458
|
|
92,550
|
Net income attributable
to Quaker Chemical Corporation common shareholders –
diluted
|
1.81
|
|
1.87
|
|
5.70
|
|
5.14
|
Non-GAAP net income
*
|
33,981
|
|
36,928
|
|
109,886
|
|
105,694
|
Non-GAAP Earnings per
diluted share *
|
1.89
|
|
2.05
|
|
6.11
|
|
5.87
|
Adjusted EBITDA
*
|
78,562
|
|
84,381
|
|
246,135
|
|
243,414
|
|
* Refer
to the Non-GAAP Measures and Reconciliations section below for
additional information
|
Third Quarter 2024 Consolidated Results
Net sales in the third quarter of 2024 were $462.3 million, a decline of approximately 6%
compared to $490.6 million in the
third quarter of 2023. This result was due to a decrease in selling
price and product mix of approximately 4%, which is primarily
attributable to the impact of index based customer contracts, a
decline in sales volumes of approximately 1% primarily reflecting a
continuation of soft end market conditions, partially offset by new
business wins, and an unfavorable impact from foreign currency
translation of 1%.
The Company reported net income in the third quarter of 2024 of
$32.3 million, or $1.81 per diluted share, compared to net income
of $33.7 million, or $1.87 per diluted share, in the third quarter of
2023. Excluding non-recurring and non-core items in each period,
the Company's non-GAAP net income and earnings per diluted share
were $34.0 million and $1.89 respectively in the third quarter of 2024
compared to $36.9 million and
$2.05 respectively in the prior year.
The Company generated adjusted EBITDA of $78.6 million in the third quarter of 2024, a
decrease of 7% compared to $84.4
million in the third quarter of 2023, primarily driven by
the decline in net sales as mentioned above.
Andy Tometich, Chief Executive
Officer and President, commented, "The third quarter once again
highlighted the resilience of Quaker Houghton. While end market
conditions softened compared to the second quarter of 2024, our
volumes remained consistent, driven by new business wins across our
portfolio. We continue to perform well on our financial and
operational priorities. Our segment operating margins have improved
year-to-date, as we simplify our portfolio, and remain disciplined
with our costs and investments, balancing our long-term objectives
with the near-term market environment.
"Looking ahead, we anticipate the current difficult market
conditions will likely persist through the end of the year. Our
focus remains on executing on what we can control, driving
efficiencies and productivity for our Company and our customers. We
are confident in the long-term positive fundamentals of the
industry we serve and will further advance our enterprise strategy.
Our investments will strengthen our ability to continue to deliver
above market growth, especially as end markets recover.
Additionally, our balance sheet and cash generation remain strong,
providing avenues to accelerate our growth and enhance shareholder
value."
Third Quarter 2024 Segment Results
The Company's third quarter 2024 operating performance for each
of its three reportable segments: (i) Americas; (ii) EMEA; and
(iii) Asia/Pacific, is further
described below.
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net Sales
*
|
|
|
|
|
|
|
|
Americas
|
$
220,275
|
|
$
245,899
|
|
$
673,546
|
|
$
750,531
|
EMEA
|
134,135
|
|
139,620
|
|
410,558
|
|
435,602
|
Asia/Pacific
|
107,864
|
|
105,093
|
|
311,496
|
|
300,071
|
Total net
sales
|
$
462,274
|
|
$
490,612
|
|
$ 1,395,600
|
|
$ 1,486,204
|
Segment operating
earnings *
|
|
|
|
|
|
|
|
Americas
|
$
62,121
|
|
$
69,148
|
|
$
193,027
|
|
$
204,280
|
EMEA
|
24,644
|
|
27,922
|
|
80,867
|
|
81,076
|
Asia/Pacific
|
30,656
|
|
30,963
|
|
92,033
|
|
86,604
|
Total segment
operating earnings
|
$
117,421
|
|
$
128,033
|
|
$
365,927
|
|
$
371,960
|
|
* Refer
to the Segment Measures and Reconciliations section below for
additional information
|
Net sales in the Asia/Pacific
segment increased in the third quarter of 2024 compared to the same
period in 2023 due to an increase in sales volumes and a favorable
impact of foreign currency translation, partially offset by a
decline in selling price and product mix. Net sales in the Americas
segment declined in the third quarter of 2024 compared to the same
period in 2023 due to a decline in sales volumes and selling price
and product mix, and an unfavorable impact of foreign currency
translation. Net sales in the EMEA segment declined in the
third quarter of 2024 compared to the same period in 2023 due to a
decline in selling price and product mix, partially offset by an
increase in sales volumes and a favorable impact of foreign
currency translation.
The decline in selling price and product mix in the third
quarter of 2024 compared to the same period in 2023 primarily
reflects the impact of our index-based customer contracts. Sales
volumes increased in the Asia/Pacific segment primarily due to
continued new business wins and a modest improvement in market
conditions. The Americas and EMEA segments continue to be
impacted by a continuation of softer end market conditions, for
metal and metalworking applications, compared to the prior year,
partially offset by new business wins.
Compared to the second quarter of 2024, net sales in the
Americas and EMEA segments declined due to lower sales volumes,
reflecting continued and broad end market challenges, particularly
for automotive and industrial applications. Net sales in the
Asia/Pacific segment increased
compared to the second quarter of 2024, primarily due to an
increase in sales volumes, driven by new business wins, partially
offset by a decline in selling price and product mix. The impact of
foreign currency translation was favorable to the EMEA and
Asia/Pacific segments and
unfavorable in the Americas segment, compared to the prior
quarter.
Operating earnings decreased in all segments in the third
quarter of 2024 compared to the prior year. Segment operating
margins increased in the Americas segment and declined in
the EMEA and Asia/Pacific
segments in the third quarter of 2024 compared to the prior year.
Operating earnings and operating margins declined in all segments
in the third quarter of 2024 compared to the second quarter of
2024.
Cash Flow and Liquidity Highlights
Net cash provided by operating activities was $141.5 million for the nine months ended
September 30, 2024, compared to net
cash provided by operating activities of $199.5 million for the same period in 2023.
The Company's operating cash flow reflects higher outflows to fund
ongoing working capital requirements.
As of September 30, 2024, the Company's total gross debt
was $740.6 million and its cash and
cash equivalents was $212.1 million,
which resulted in net debt of approximately $528.6 million. The Company's net debt divided by
its trailing twelve months adjusted EBITDA was approximately 1.6x.
In the third quarter of 2024, the Company repurchased 89,088 shares
for approximately $14.6 million and
138,000 shares for approximately $22.9
million in the nine months ended September 30,
2024.
Non-GAAP Measures and Reconciliations
The information included in this press release includes non-GAAP
(unaudited) financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP
operating margin, taxes on income before equity in net income of
associated companies – adjusted, non-GAAP net income and non-GAAP
earnings per diluted share. The Company believes these non-GAAP
financial measures provide meaningful supplemental information as
they enhance a reader's understanding of the Company's financial
performance and facilitate a comparison among fiscal periods, as
the non-GAAP financial measures exclude items that are not
indicative of future operating performance or not considered core
to the Company's operations. Non-GAAP results are presented for
supplemental informational purposes only and should not be
considered a substitute for the financial information presented in
accordance with GAAP. In addition, our definitions of EBITDA,
adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income,
non-GAAP operating margin, taxes on income before equity in net
income of associated companies – adjusted, non-GAAP net income and
non-GAAP earnings per diluted share as discussed and reconciled
below to the most comparable respective GAAP measures, may not be
comparable to similarly named measures reported by other
companies.
The Company presents EBITDA which is calculated as net income
attributable to the Company before depreciation and amortization,
interest expense, net, and taxes on income before equity in net
income of associated companies. The Company also presents adjusted
EBITDA which is calculated as EBITDA plus or minus certain items
that are not indicative of future operating performance or not
considered core to the Company's operations. In addition, the
Company presents non-GAAP operating income which is calculated as
operating income plus or minus certain items that are not
considered indicative of future operating performance or not
considered core to the Company's operations. Adjusted EBITDA margin
and non-GAAP operating margin are calculated as the percentage of
adjusted EBITDA and non-GAAP operating income to consolidated net
sales, respectively. The Company believes these non-GAAP measures
provide transparent and useful information and are widely used by
investors, analysts, and peers in our industry as well as by
management in assessing the operating performance of the Company on
a consistent basis.
Additionally, the Company presents non-GAAP net income and
non-GAAP earnings per diluted share as additional performance
measures. Non-GAAP net income is calculated as adjusted EBITDA,
defined above, less depreciation and amortization, interest
expense, net, and taxes on income before equity in net income of
associated companies, in each case adjusted, as applicable, for any
depreciation, amortization, interest or tax impacts resulting from
the non-core items identified in the reconciliation of net income
attributable to the Company to adjusted EBITDA. Non-GAAP earnings
per diluted share is calculated as non-GAAP net income per diluted
share as accounted for under the "two-class share method." The
Company believes that non-GAAP net income and non-GAAP earnings per
diluted share provide transparent and useful information and are
widely used by investors, analysts, and peers in our industry as
well as by management in assessing the operating performance of the
Company on a consistent basis.
As it relates to future projections for the Company as well as
other forward-looking information contained in this press release,
the Company has not provided guidance for comparable GAAP measures
or a quantitative reconciliation of forward-looking non-GAAP
financial measures to the most directly comparable U.S. GAAP
measure because it is unable to determine with reasonable certainty
the ultimate outcome of certain significant items necessary to
calculate such measures without unreasonable effort. These items
include, but are not limited to, certain non-recurring or non-core
items the Company may record that could materially impact net
income. These items are uncertain, depend on various factors, and
could have a material impact on the U.S. GAAP reported results for
the guidance period.
The Company's reference to trailing twelve months adjusted
EBITDA within this press release refers to the twelve month period
ended September 30, 2024 adjusted EBITDA of $323.1 million, which consists of (i) the nine
months ended September 30, 2024 adjusted EBITDA of
$246.1 million, as presented in the
non-GAAP reconciliations below, and (ii) the twelve months ended
December 31, 2023 adjusted EBITDA of $320.4 million, as presented in the non-GAAP
reconciliations included in the Company's fourth quarter and full
year 2023 results press release dated February 29, 2024, less (iii) the nine months
ended September 30, 2023 adjusted EBITDA of $243.4 million, as presented in the non-GAAP
reconciliations below.
Certain of the prior period non-GAAP financial measures
presented in the following tables have been adjusted to conform
with current period presentation. The following tables reconcile
the Company's non-GAAP financial measures (unaudited) to their most
directly comparable GAAP (unaudited) financial measures (dollars in
thousands unless otherwise noted, except per share amounts):
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
Non-GAAP Operating
Income and Margin Reconciliations:
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Operating
income
|
$
51,718
|
|
$
59,518
|
|
$
165,693
|
|
$
166,242
|
Restructuring and
related charges, net
|
2,610
|
|
1,019
|
|
4,787
|
|
6,034
|
Strategic planning
(credits) expenses
|
(181)
|
|
1,093
|
|
(290)
|
|
3,759
|
Customer insolvency
costs
|
—
|
|
—
|
|
1,522
|
|
—
|
Other
charges
|
43
|
|
206
|
|
1,535
|
|
855
|
Non-GAAP operating
income
|
$
54,190
|
|
$
61,836
|
|
$
173,247
|
|
$
176,890
|
Non-GAAP operating
margin (%)
|
11.7 %
|
|
12.6 %
|
|
12.4 %
|
|
11.9 %
|
EBITDA, Adjusted
EBITDA, Adjusted EBITDA Margin and
Non-GAAP Net Income Reconciliations:
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net income attributable
to Quaker Chemical Corporation
|
$
32,346
|
|
$
33,670
|
|
$
102,458
|
|
$
92,550
|
Depreciation and
amortization (a)
|
21,423
|
|
20,866
|
|
63,907
|
|
62,210
|
Interest expense,
net
|
10,347
|
|
12,781
|
|
31,925
|
|
38,744
|
Taxes on income before
equity in net income of associated companies (b)
|
12,167
|
|
13,593
|
|
40,453
|
|
36,956
|
EBITDA
|
76,283
|
|
80,910
|
|
238,743
|
|
230,460
|
Equity income in a
captive insurance company
|
(285)
|
|
(756)
|
|
(1,266)
|
|
(748)
|
Restructuring and
related charges, net
|
2,610
|
|
1,019
|
|
4,787
|
|
6,034
|
Strategic planning
(credits) expenses
|
(181)
|
|
1,093
|
|
(290)
|
|
3,759
|
Customer insolvency
costs
|
—
|
|
—
|
|
1,522
|
|
—
|
Facility remediation
recoveries
|
—
|
|
—
|
|
—
|
|
(1,014)
|
Product liability claim
costs
|
—
|
|
—
|
|
896
|
|
—
|
Business interruption
insurance proceeds
|
(1,000)
|
|
—
|
|
(1,000)
|
|
—
|
Currency conversion
impacts of hyper-inflationary economies
|
624
|
|
1,229
|
|
333
|
|
2,869
|
Other
charges
|
511
|
|
886
|
|
2,410
|
|
2,054
|
Adjusted
EBITDA
|
$
78,562
|
|
$
84,381
|
|
$
246,135
|
|
$
243,414
|
Adjusted EBITDA margin
(%)
|
17.0 %
|
|
17.2 %
|
|
17.6 %
|
|
16.4 %
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
$
78,562
|
|
$
84,381
|
|
$
246,135
|
|
$
243,414
|
Less: Depreciation and
amortization (a)
|
21,423
|
|
20,866
|
|
63,907
|
|
62,210
|
Less: Interest expense,
net
|
10,347
|
|
12,781
|
|
31,925
|
|
38,744
|
Less: Taxes on income
before equity in net income of associated companies - adjusted
(b)
|
12,811
|
|
13,806
|
|
40,417
|
|
36,766
|
Non-GAAP net
income
|
$
33,981
|
|
$
36,928
|
|
$
109,886
|
|
$
105,694
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
Non-GAAP Earnings
per Diluted Share Reconciliations:
|
2024
|
|
2023
|
|
2024
|
|
2023
|
GAAP earnings per
diluted share attributable to Quaker Chemical Corporation common
shareholders
|
$
1.81
|
|
$
1.87
|
|
$
5.70
|
|
$
5.14
|
Equity income in a
captive insurance company per diluted share
|
(0.02)
|
|
(0.04)
|
|
(0.07)
|
|
(0.04)
|
Restructuring and
related charges, net per diluted share
|
0.11
|
|
0.04
|
|
0.20
|
|
0.25
|
Strategic planning
(credits) expenses per diluted share
|
(0.01)
|
|
0.04
|
|
(0.01)
|
|
0.17
|
Customer insolvency
costs per diluted share
|
—
|
|
—
|
|
0.06
|
|
—
|
Facility remediation
recoveries per diluted share
|
—
|
|
—
|
|
—
|
|
(0.05)
|
Product liability claim
costs per diluted share
|
—
|
|
—
|
|
0.04
|
|
—
|
Business interruption
insurance proceeds per diluted share
|
(0.04)
|
|
—
|
|
(0.04)
|
|
—
|
Currency conversion
impacts of hyper-inflationary economies per diluted
share
|
0.04
|
|
0.07
|
|
0.02
|
|
0.16
|
Other charges per
diluted share
|
0.02
|
|
0.04
|
|
0.10
|
|
0.08
|
Impact of certain
discrete tax items per diluted share
|
(0.02)
|
|
0.03
|
|
0.11
|
|
0.16
|
Non-GAAP earnings per
diluted share
|
$
1.89
|
|
$
2.05
|
|
$
6.11
|
|
$
5.87
|
|
|
a.
|
Depreciation and
amortization for the three and nine months ended September 30,
2024 and 2023 includes approximately $0.2 million and $0.7 million,
respectively, and $0.3 million and $0.8 million, respectively, of
amortization expense recorded within equity in net income of
associated companies in the Company's Condensed Consolidated
Statements of Operations, which is attributable to the amortization
of the fair value step up for the Company's 50% interest in a joint
venture in Korea as a result of required purchase
accounting.
|
b.
|
Taxes on income
before equity in net income of associated companies – adjusted
includes the Company's tax expense adjusted for the impact of any
current and deferred income tax expense (benefit), as applicable,
of the reconciling items presented in the reconciliation of Net
income attributable to Quaker Chemical Corporation to adjusted
EBITDA, above, determined utilizing the applicable rates in the
taxing jurisdictions in which these adjustments occurred, subject
to deductibility. This caption also includes the impact of specific
tax charges and benefits in the nine months ended September 30,
2024 and 2023, which the Company does not consider core to the
Company's operations or indicative of future
performance.
|
Segment Measures and Reconciliations
Segment operating earnings for each of the Company's reportable
segments are comprised of the segment's net sales less directly
related Cost of goods sold ("COGS") and Selling, general and
administrative expenses ("SG&A"). Operating expenses not
directly attributable to the net sales of each respective segment,
such as certain corporate and administrative costs and
Restructuring and related charges, net, are not included in segment
operating earnings. Other items not specifically identified with
the Company's reportable segments include Interest expense, net and
Other income (expense), net.
The following table presents information about the performance
of the Company's reportable segments (dollars in thousands):
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
Sales
|
|
|
|
|
|
|
|
Americas
|
$
220,275
|
|
$
245,899
|
|
$
673,546
|
|
$
750,531
|
EMEA
|
134,135
|
|
139,620
|
|
410,558
|
|
$
435,602
|
Asia/Pacific
|
107,864
|
|
105,093
|
|
311,496
|
|
$
300,071
|
Total net
sales
|
$
462,274
|
|
$
490,612
|
|
$ 1,395,600
|
|
$ 1,486,204
|
Segment operating
earnings
|
|
|
|
|
|
|
|
Americas
|
$
62,121
|
|
$
69,148
|
|
$
193,027
|
|
$
204,280
|
EMEA
|
24,644
|
|
27,922
|
|
80,867
|
|
$
81,076
|
Asia/Pacific
|
30,656
|
|
30,963
|
|
92,033
|
|
$
86,604
|
Total segment
operating earnings
|
117,421
|
|
128,033
|
|
365,927
|
|
371,960
|
Restructuring and
related charges, net
|
(2,610)
|
|
(1,019)
|
|
(4,787)
|
|
(6,034)
|
Non-operating and
administrative expenses
|
(47,778)
|
|
(52,280)
|
|
(149,538)
|
|
(154,001)
|
Depreciation of
corporate assets and amortization
|
(15,315)
|
|
(15,216)
|
|
(45,909)
|
|
(45,683)
|
Operating
income
|
51,718
|
|
59,518
|
|
165,693
|
|
166,242
|
Other income (expense),
net
|
783
|
|
(2,713)
|
|
2,285
|
|
(8,558)
|
Interest expense,
net
|
(10,347)
|
|
(12,781)
|
|
(31,925)
|
|
(38,744)
|
Income before taxes
and equity in net income of associated companies
|
$
42,154
|
|
$
44,024
|
|
$
136,053
|
|
$
118,940
|
Forward-Looking Statements
This press release contains "forward-looking statements" that
fall under the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 and the Securities Act of 1933, as
amended. These statements can be identified by the fact that they
do not relate strictly to historical or current facts. We have
based these forward-looking statements on assumptions, projections
and expectations about future events that we believe are reasonable
based on currently available information, including statements
regarding the potential effects of the conflicts in Ukraine and the Middle East; inflation and global supply chain
constraints on the Company's business, results of operations, and
financial condition; our expectation that we will maintain
sufficient liquidity and remain in compliance with the terms of the
Company's credit facility; expectations about future demand and raw
material costs; and statements regarding the impact of increased
raw material costs and pricing initiatives. These forward-looking
statements include statements with respect to our beliefs, plans,
objectives, goals, expectations, anticipations, intentions,
financial condition, results of operations, future performance, and
business, which may differ materially from our actual results,
including but not limited to the potential benefits of acquisitions
and divestitures, the impacts on our business as a result of global
supply chain constraints, and our current and future results and
plans and statements that include the words "may," "could,"
"should," "would," "believe," "expect," "anticipate," "estimate,"
"intend," "outlook, "target", "possible", "potential", "plan" or
similar expressions. A major risk is that demand for the Company's
products and services is largely derived from the demand for its
customers' products, which subjects the Company to uncertainties
related to downturns in a customer's business and unanticipated
customer production slowdowns and shutdowns. Other major risks and
uncertainties include, but are not limited to inflationary
pressures, including the potential for significant increases in raw
material costs; supply chain disruptions; customer financial
instability; high interest rates and the possibility of economic
recession; economic and political disruptions particularly in light
of numerous elections globally and the possibility of regime
changes, including the impacts of the military conflicts between
Russia and Ukraine and in the Middle East; legislative and regulatory
developments including changes to existing laws and regulations, or
the way they are interpreted, applied or enforced; tariffs, trade
restrictions, and the economic and other sanctions imposed by other
nations on Russia and Belarus
and/or other government organizations; suspensions of activities in
Russia by many multinational
companies and the potential expansion of military activity; foreign
currency fluctuations; significant changes in applicable tax rates
and regulations; future terrorist attacks and other acts of
violence; the impacts of consolidation in our industry, including
loss or consolidation of a major customer; and the potential
occurrence of cyber-security breaches, cyber-security attacks and
other technology outages and security incidents. Furthermore, the
Company is subject to the same business cycles as those experienced
by our customers in the steel, automobile, aircraft, industrial
equipment, aluminum and durable goods industries. Our
forward-looking statements are subject to risks, uncertainties and
assumptions about the Company and its operations that are subject
to change based on various important factors, some of which are
beyond our control. These risks, uncertainties, and possible
inaccurate assumptions relevant to our business could cause our
actual results to differ materially from expected and historical
results. All forward-looking statements included in this press
release, including expectations about business conditions during
2024 and future periods, are based upon information available to
the Company as of the date of this press release, which may change.
Therefore, we caution you not to place undue reliance on our
forward-looking statements. For more information regarding these
risks and uncertainties as well as certain additional risks that we
face, refer to the Risk Factors section, which appears in Item 1A
of our Annual Report on Form 10-K for the year ended December 31, 2023, and in subsequent reports
filed from time to time with the Securities and Exchange
Commission. We do not intend to, and we disclaim any duty or
obligation to, update or revise any forward-looking statements to
reflect new information or future events or for any other reason.
This discussion is provided as permitted by the Private Securities
Litigation Reform Act of 1995.
Conference Call
As previously announced, the Company's investor conference call
to discuss its third quarter of 2024 performance is scheduled for
Friday, November 1, 2024 at
8:30 a.m. ET. A live webcast of the
conference call, together with supplemental information, can be
accessed through the Company's Investor Relations website at
investors.quakerhoughton.com. You can also access the conference
call by dialing 877-269-7756.
About Quaker Houghton
Quaker Houghton is the global leader in industrial process
fluids. With a presence around the world, including operations in
over 25 countries, our customers include thousands of the world's
most advanced and specialized steel, aluminum, automotive,
aerospace, offshore, container, mining, and metalworking companies.
Our high-performing, innovative and sustainable solutions are
backed by best-in-class technology, deep process knowledge and
customized services. With approximately 4,400 employees, including
chemists, engineers and industry experts, we partner with our
customers to improve their operations so they can run even more
efficiently, even more effectively, whatever comes next. Quaker
Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the
United States. Visit quakerhoughton.com to learn
more.
Quaker Chemical
Corporation
Condensed Consolidated Statements of Operations
(Unaudited; Dollars in thousands, except per share
data)
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net sales
|
$
462,274
|
|
$
490,612
|
|
$ 1,395,600
|
|
$ 1,486,204
|
Cost of goods
sold
|
289,725
|
|
307,265
|
|
865,770
|
|
951,716
|
Gross profit
|
172,549
|
|
183,347
|
|
529,830
|
|
534,488
|
Selling, general and
administrative expenses
|
118,221
|
|
122,810
|
|
359,350
|
|
362,212
|
Restructuring and
related charges, net
|
2,610
|
|
1,019
|
|
4,787
|
|
6,034
|
Operating
income
|
51,718
|
|
59,518
|
|
165,693
|
|
166,242
|
Other income (expense),
net
|
783
|
|
(2,713)
|
|
2,285
|
|
(8,558)
|
Interest expense,
net
|
(10,347)
|
|
(12,781)
|
|
(31,925)
|
|
(38,744)
|
Income before taxes and
equity in net income of associated companies
|
42,154
|
|
44,024
|
|
136,053
|
|
118,940
|
Taxes on income before
equity in net income of associated companies
|
12,167
|
|
13,593
|
|
40,453
|
|
36,956
|
Income before equity in
net income of associated companies
|
29,987
|
|
30,431
|
|
95,600
|
|
81,984
|
Equity in net income of
associated companies
|
2,385
|
|
3,279
|
|
6,940
|
|
10,660
|
Net income
|
32,372
|
|
33,710
|
|
102,540
|
|
92,644
|
Less: Net income
attributable to noncontrolling interest
|
26
|
|
40
|
|
82
|
|
94
|
Net income attributable
to Quaker Chemical Corporation
|
$
32,346
|
|
$
33,670
|
|
$
102,458
|
|
$
92,550
|
Per share
data:
|
|
|
|
|
|
|
|
Net income attributable
to Quaker Chemical Corporation common shareholders –
basic
|
$
1.81
|
|
$
1.87
|
|
$
5.71
|
|
$
5.15
|
Net income attributable
to Quaker Chemical Corporation common shareholders –
diluted
|
$
1.81
|
|
$
1.87
|
|
$
5.70
|
|
$
5.14
|
Basic weighted average
common shares outstanding
|
17,837,858
|
|
17,908,754
|
|
17,889,168
|
|
17,889,444
|
Diluted weighted
average common shares outstanding
|
17,864,335
|
|
17,921,274
|
|
17,909,967
|
|
17,906,153
|
Quaker Chemical
Corporation
Condensed Consolidated Balance Sheets
(Unaudited; Dollars in thousands, except par
value)
|
|
|
|
|
|
September
30,
2024
|
|
December 31,
2023
|
ASSETS
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
212,074
|
|
$
194,527
|
Accounts receivable,
net
|
422,732
|
|
444,950
|
Inventories
|
244,988
|
|
233,857
|
Prepaid expenses and
other current assets
|
62,059
|
|
54,555
|
Total current
assets
|
941,853
|
|
927,889
|
|
|
|
|
Property, plant and
equipment, net
|
215,555
|
|
207,811
|
Right-of-use lease
assets
|
35,408
|
|
38,614
|
Goodwill
|
532,523
|
|
512,518
|
Other intangible
assets, net
|
874,806
|
|
896,721
|
Investments in
associated companies
|
103,444
|
|
101,151
|
Deferred tax
assets
|
12,172
|
|
10,737
|
Other non-current
assets
|
19,920
|
|
18,770
|
Total
assets
|
$
2,735,681
|
|
$ 2,714,211
|
|
|
|
|
LIABILITIES AND
EQUITY
|
|
|
|
Current
liabilities
|
|
|
|
Short-term borrowings
and current portion of long-term debt
|
$
38,787
|
|
$
23,444
|
Accounts
payable
|
191,788
|
|
184,813
|
Dividends
payable
|
8,658
|
|
8,186
|
Accrued
compensation
|
38,741
|
|
55,194
|
Accrued
restructuring
|
1,727
|
|
3,350
|
Accrued pension and
postretirement benefits
|
2,182
|
|
2,208
|
Other accrued
liabilities
|
89,462
|
|
90,315
|
Total current
liabilities
|
371,345
|
|
367,510
|
|
|
|
|
Long-term
debt
|
700,648
|
|
730,623
|
Long-term lease
liabilities
|
20,610
|
|
22,937
|
Deferred tax
liabilities
|
143,219
|
|
146,957
|
Non-current accrued
pension and postretirement benefits
|
25,752
|
|
29,457
|
Other non-current
liabilities
|
27,837
|
|
31,805
|
Total
liabilities
|
1,289,411
|
|
1,329,289
|
|
|
|
|
Equity
|
|
|
|
Common stock $1 par
value; authorized 30,000,000 shares; issued and
outstanding
September 30, 2024 – 17,852,066 shares; December 31, 2023 –
17,991,988 shares
|
17,852
|
|
17,992
|
Capital in excess of
par value
|
928,156
|
|
940,101
|
Retained
earnings
|
628,103
|
|
550,641
|
Accumulated other
comprehensive loss
|
(128,448)
|
|
(124,415)
|
Total Quaker
shareholders' equity
|
1,445,663
|
|
1,384,319
|
Noncontrolling
interest
|
607
|
|
603
|
Total
equity
|
1,446,270
|
|
1,384,922
|
Total liabilities and
equity
|
$
2,735,681
|
|
$ 2,714,211
|
Quaker Chemical
Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited; Dollars in thousands)
|
|
|
|
Nine Months
Ended
September 30,
|
|
2024
|
|
2023
|
Cash flows from
operating activities
|
|
|
|
Net income
|
$
102,540
|
|
$
92,644
|
Adjustments to
reconcile net income to net cash used in operating
activities:
|
|
|
|
Amortization of debt
issuance costs
|
1,059
|
|
1,059
|
Depreciation and
amortization
|
63,159
|
|
61,434
|
Equity in
undistributed earnings of associated companies, net of
dividends
|
1,045
|
|
(7,486)
|
Deferred income
taxes
|
(7,934)
|
|
(1,591)
|
Deferred compensation
and other, net
|
(1,428)
|
|
1,076
|
Share-based
compensation
|
12,413
|
|
11,189
|
Restructuring and
related charges, net
|
4,787
|
|
6,034
|
Pension and other
postretirement benefits
|
(3,956)
|
|
(2,000)
|
(Decrease) increase in
cash from changes in current assets and current liabilities, net of
acquisitions:
|
|
|
|
Accounts
receivable
|
20,625
|
|
22,133
|
Inventories
|
(10,875)
|
|
30,607
|
Prepaid expenses and
other current assets
|
(7,912)
|
|
(9,771)
|
Accrued
restructuring
|
(6,397)
|
|
(7,914)
|
Accounts payable and
accrued liabilities
|
(25,612)
|
|
2,046
|
Net cash provided by
operating activities
|
141,514
|
|
199,460
|
Cash flows from
investing activities
|
|
|
|
Investments in
property, plant and equipment
|
(19,337)
|
|
(25,794)
|
Payments related to
acquisitions, net of cash acquired
|
(39,302)
|
|
—
|
Proceeds from
disposition of assets
|
2,798
|
|
—
|
Net cash used in
investing activities
|
(55,841)
|
|
(25,794)
|
Cash flows from
financing activities
|
|
|
|
Payments of long-term
debt
|
(48,600)
|
|
(14,075)
|
Borrowings (payments)
on revolving credit facilities, net
|
30,500
|
|
(112,835)
|
(Payments) borrowings
on other debt, net
|
(842)
|
|
797
|
Dividends
paid
|
(24,523)
|
|
(23,459)
|
Shares purchased under
share repurchase programs
|
(22,906)
|
|
—
|
Other stock related
activity
|
(631)
|
|
(953)
|
Net cash used in
financing activities
|
(67,002)
|
|
(150,525)
|
Effect of foreign
exchange rate changes on cash
|
(1,124)
|
|
(5,746)
|
Net increase in cash
and cash equivalents
|
17,547
|
|
17,395
|
Cash and cash
equivalents at the beginning of the period
|
194,527
|
|
180,963
|
Cash and cash
equivalents at the end of the period
|
$
212,074
|
|
$
198,358
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-third-quarter-2024-results-302293261.html
SOURCE Quaker Chemical Corporation